title: CRP and fibrinogen imply clinical outcome of patients with Type-2 diabetes and coronary artery disease.
authors.affiliation: Medical School, University Cardiology Clinic, Skopje, Macedonia.
authors.forename: Marijan
authors.initials: M
authors.lastname: Bosevski
authors.affiliation: Medical School, University Cardiology Clinic, Skopje, Macedonia.
authors.forename: Golubinka
authors.initials: G
authors.lastname: Bosevska
authors.affiliation: Centre for Chronic Disease, College of Health and Biomedicine, Victoria University, Melbourne VIC, Australia.
authors.forename: Lily
authors.initials: L
authors.lastname: Stojanovska
authors.affiliation: Centre for Chronic Disease, College of Health and Biomedicine, Victoria University, Melbourne VIC, Australia.
authors.forename: Vasso
authors.initials: V
authors.lastname: Apostolopoulos
mesh_terms: D000787:Angina Pectoris / Q000097:blood* / Q000175:diagnosis / Q000209:etiology; D015415:Biomarkers / Q000097:blood*; D002097:C-Reactive Protein / Q000032:analysis*; D003324:Coronary Artery Disease / Q000097:blood / Q000150:complications*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications*; D005340:Fibrinogen / Q000032:analysis*; D006801:Humans; D007249:Inflammation / Q000097:blood* / Q000175:diagnosis / Q000209:etiology; D011379:Prognosis; D011446:Prospective Studies
chemical_list: D015415:Biomarkers; D005340:Fibrinogen; D002097:C-Reactive Protein